Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|April 25, 2019
Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trialsVladimir Gilca, Chantal Sauvageau, Gitika Panicker, et al.
Human Vaccines & Immunotherapeutics|September 24, 2019
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trialsChantal Sauvageau, Gitika Panicker, Elizabeth R Unger, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2019
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling studyMélanie Drolet, Zhou Zhou, Chantal Sauvageau, et al.
Vaccine|June 12, 2018
Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impactVladimir Gilca, Jorge Salmerón-Castro, Chantal Sauvageau, et al.
Human Vaccines & Immunotherapeutics|August 19, 2021
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active womenChantal Sauvageau, Vladimir Gilca, Manale Ouakki, et al.
BMC Infectious Diseases|July 9, 2005
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic reviewBa' Pham, Bernard Duval, Gaston De Serres, et al.
Human Vaccines & Immunotherapeutics|February 26, 2015
The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccineVladimir Gilca, Chantal Sauvageau, Nicole Boulianne, et al.
Pageof 7